🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate the safety and tolerabil...
Status
Completed
Location
ARG003
Start Date
2023-05-11
Trial ID
NCT05649722
Treatments Being Tested
The primary purpose of the study is to evaluate the safety and tolerability...
Status
Active Not Recruiting
Location
USA005
Start Date
2023-03-07
Trial ID
NCT05649748
Treatments Being Tested
The primary purpose of the study is to determine the effect of mild, modera...
Status
Recruiting
Location
Orlando County Research Center
Start Date
2026-07-14
Trial ID
NCT07643155
Treatments Being Tested
The primary objective of this study is to determine the relative bioavailab...
Status
Completed
Location
USA001
Start Date
2025-08-19
Trial ID
NCT07102316
The primary objective of this study is to evaluate the safety and tolerabil...
Status
Recruiting
Location
USA006
Start Date
2026-07-20
Trial ID
NCT07234032
Treatments Being Tested
The main objective of the study is to assess the effect of treprostinil pal...
Status
Completed
Location
USA025
Start Date
2022-08-24
Trial ID
NCT05147805
Treatments Being Tested
The main purpose of this study is to evaluate the safety and tolerability o...
Status
Terminated
Location
USA002
Start Date
2022-03-29
Trial ID
NCT04791514
Treatments Being Tested
The primary purpose of this study is to evaluate the safety and tolerabilit...
Status
Completed
Location
USA001
Start Date
2020-09-17
Trial ID
NCT06091579
Treatments Being Tested
The primary objective of this study is to evaluate the effect of 24-weeks o...
Status
Recruiting
Location
USA010
Start Date
2026-01-07
Trial ID
NCT07179380
Treatments Being Tested
The primary objective of this study is to evaluate the safety and tolerabil...
Status
Completed
Location
ARG003
Start Date
2022-12-22
Trial ID
NCT05176951
Treatments Being Tested